Population pharmacokinetics and pharmacodynamics of doripenem in obese patients.

被引:0
|
作者
Chung, Eun Kyoung [1 ]
Cheatham, S. Christian [2 ]
Fleming, Megan R. [3 ]
Kays, Michael B. [1 ]
机构
[1] Purdue Univ, Coll Pharm, Dept Pharm Practice, Indianapolis, IN USA
[2] Franciscan St Francis Hlth Indianapolis, Dept Pharm, Indianapolis, IN USA
[3] Methodist Dallas Med Ctr, Dallas, TX USA
来源
PHARMACOTHERAPY | 2013年 / 33卷 / 10期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
125
引用
收藏
页码:E220 / E220
页数:1
相关论文
共 50 条
  • [21] Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis
    Alghamdi, Wael A.
    Alsultan, Abdullah
    Al-Shaer, Mohammad H.
    An, Guohua
    Ahmed, Shahriar
    Alkabab, Yosra
    Banu, Sayera
    Barbakadze, Ketevan
    Houpt, Eric
    Kipiani, Maia
    Mikiashvili, Lali
    Schmidt, Stephan
    Heysell, Scott K.
    Kempker, Russell R.
    Cegielski, J. Peter
    Peloquin, Charles A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (05)
  • [22] Population pharmacokinetics and pharmacodynamics of ustekinumab in patients with psoriasis
    Teeuwisse, P.
    Atalay, S.
    Berends, S.
    Reek, J.
    Njoo, M.
    de Vries, A.
    Mommers, R.
    Ossenkoppele, P.
    Koetsier, M.
    Berends, M.
    de Jong, E.
    Mathot, R.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S106 - S106
  • [23] Population pharmacokinetics and pharmacodynamics of meropenem in pediatric patients
    Du, XL
    Li, CH
    Kuti, JL
    Nightingale, CH
    Nicolau, DP
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (01): : 69 - 75
  • [24] Population pharmacokinetics/pharmacodynamics of micafungin against Candida species in obese, critically ill, and morbidly obese critically ill patients
    Maseda, Emilio
    Grau, Santiago
    Luque, Sonia
    Castillo-Mafla, Maria-Pilar
    Suarez-de-la-Rica, Alejandro
    Montero-Feijoo, Ana
    Salgado, Patricia
    Gimenez, Maria-Jose
    Garcia-Bernedo, Carlos A.
    Gilsanz, Fernando
    Roberts, Jason A.
    CRITICAL CARE, 2018, 22
  • [25] Population pharmacokinetics/pharmacodynamics of micafungin against Candida species in obese, critically ill, and morbidly obese critically ill patients
    Emilio Maseda
    Santiago Grau
    Sonia Luque
    Maria-Pilar Castillo-Mafla
    Alejandro Suárez-de-la-Rica
    Ana Montero-Feijoo
    Patricia Salgado
    Maria-Jose Gimenez
    Carlos A. García-Bernedo
    Fernando Gilsanz
    Jason A. Roberts
    Critical Care, 22
  • [26] POPULATION PHARMACOKINETICS OF PROTHIONAMIDE IN KOREAN PATIENTS.
    Seong, S.
    Lee, J.
    Park, S.
    Lim, M.
    Park, J.
    Seo, J.
    Lee, H.
    Yoon, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S87 - S87
  • [27] Population pharmacokinetics of pixantrone in cancer patients.
    Bernareggi, A
    Allievil, C
    Hussein, Z
    Pitsiu, M
    Nell, HAB
    Aarons, L
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6247S - 6247S
  • [28] POPULATION PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF ETRUMADENANT (AB928) IN HEALTHY VOLUNTEERS AND CANCER PATIENTS.
    Wu, H.
    Liao, K.
    Nguyen, L.
    Seitz, L.
    Jin, L.
    Criste, R.
    Wang, B.
    Agoram, B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S57 - S57
  • [29] Population pharmacokinetics/pharmacodynamics (PK/PD) of UK-279,276 (NIF) in healthy volunteers and patients.
    Jonsson, EN
    MacIntyre, F
    James, I
    Wild, W
    Karlsson, MO
    Marshall, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P54 - P54
  • [30] Enoxaparin pharmacokinetics and pharmacodynamics in obese subjects
    Sanderink, GJ
    Le Liboux, A
    Jariwala, N
    Harding, N
    Ozoux, ML
    Shukla, U
    Montay, G
    Boutouyrie, B
    Miro, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 229A - 229A